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Chronic pancreatitis (CP) is a progressive irreversible in-
fl ammatory disease that eventually leads to an impaired ex-
ocrine and/or endocrine function of  the pancreas[1-4]. Al-
though most cases have been attributed to alcohol abuse, 
the underlying causes of  CP appear to be multi-faceted, 
including environmental as well as genetic factors. Chronic 
pancreatitis shares risk factors with pancreatic cancer 
such as smoking and alcohol abuse, but itself  is also a risk 
factor for pancreatic adenocarcinoma[5]. A genetic predis-
position to pancreatitis is supported by the identifi cation 
of  sequence alterations in the genes encoding cationic 
trypsinogen (PRSS1), the cystic fibrosis transmembrane 
conductance regulator (CFTR), and the serine protease in-
hibitor, Kazal type 1 (SPINK1) in patients with hereditary 
or idiopathic chronic pancreatitis[1,6-8]. Additionally, an in-
creased frequency of  SPINK1 mutations been reported in 
patients with alcohol-related chronic pancreatitis[3,9]. So far 
we have not completely understood the pathogenesis of  
CP[10]. Different hypotheses have been proposed, including 
the contribution of  oxidative stress of  endogenous origin 
or chemical stress by environmental or lifestyle-related xe-
nobiotics[11-15]. There is growing recognition that an imbal-
ance between reactive oxygen species (ROS) producing and 
ROS scavenging processes leads to the damage of  pancre-
atic acinar cells, initiating auto-digestion of  the entire pan-
creas. This insight is suggested by data from experimental 
and clinical studies[16-19]. Oxidative stress may be important 
in the pathogenesis of  ethanol-induced pancreatic injury, 
although radiation, exposure to cigarette smoke, medica-
tion or trauma may stimulate the generation of  free radi-
cals, which subsequently may result in damage of  lipids, 
proteins or nucleic acids. Activation of  (enzymatic) anti-
oxidative defence has been described in pancreatic disease 
independent of  its origin[20]. Glutathione and cysteine are 
important mediators in the defence against oxidative stress 
and both molecules play a key role in the maintenance of  
cellular thiol redox status. Therefore, in the present study 
the concentrations of  glutathione, cysteine and other thi-
ols were measured in blood plasma of  patients with CP 
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Abstract
AIM: To assess the levels of antioxidant capacity and 
oxidative damage in blood of chronic pancreatitis (CP) 
patients in comparison with those in healthy control sub-
jects, by using several different analytical techniques.
METHODS: Thirty-fi ve CP patients and 35 healthy con-
trol subjects were investigated prospectively with re-
spect to plasma levels of thiols, ferric reducing ability of 
plasma (FRAP, i.e. antioxidant capacity), levels of protein 
carbonyls and thiobarbituric acid reactive substances 
(TBARS). Additionally, we evaluated the production of 
reactive oxygen species (ROS) in whole blood.
RESULTS: The antioxidative thiols including cysteine, 
cysteinylglycine and glutathione were signifi cantly lower 
in CP patients. In addition, the non-enzymatic antioxi-
dant capacity was significantly lower in CP patients, 
which correlated with the amount of oxidative protein 
(protein carbonyls) and the extent of lipid damage 
(TBARS), both were signifi cantly higher in CP patients. 
The ROS production in whole blood after stimulation with 
phorbol 12-myritate 13-acetaat, demonstrated a strong 
tendency to produce more ROS in CP patients.
CONCLUSION: Oxidative stress may contribute to the 
pathogenesis of chronic pancreatitis by decreasing anti-
oxidant capacity and increasing oxidative damage in CP 
patients may be a rationale for intervention with antioxi-
dant therapy.
© 2006 The WJG Press. All rights reserved.
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and healthy control subjects. In addition, we also measured 
the non-enzymatic antioxidant capacity by applying the 
ferric reducing ability of  plasma (FRAP) assay in patients 
with CP and healthy controls. Further assessment of  the 
level of  oxidative stress was performed by measuring the 
concentrations of  protein carbonyls in plasma in order to 
determine the amount of  oxidative protein damage. As an 
indicator of  lipid peroxidation we established the concen-
trations of  thiobarbituric acid-reactive substances (TBARS). 
Finally, we investigated the generation of  ROS by chemilu-
minescence in whole blood of  both patients and controls.
MATERIALS AND METHODS
Subjects
The study was approved by the local medical ethical review 
committee and all subjects gave their written informed 
consent. This study was conducted at the Department 
of  Gastroenterology of  the University Medical Centre 
Nijmegen, the Netherlands and all subjects studied were 
Caucasians of  Dutch extraction. A total of  35 consecu-
tive CP patients were recruited between January 2004 and 
June 2004 at the out-patient clinic of  the department. 
In 29 patients an alcohol-related etiology was indicated 
(ACP), the remaining 6 CP patients had a family history 
of  CP (HCP). The clinical diagnosis of  CP was based on 
one or more of  the following criteria: presence of  typi-
cal complaints (recurrent upper abdominal pain, radiating 
to the back, relieved by leaning forward or sitting upright 
and increased after eating), suggestive radiological find-
ings such as pancreatic calcifi cations or pseudocysts, and 
pathological findings (pancreatic ductal irregularities and 
dilatations) revealed by endoscopic retrograde pancreati-
cography or magnetic resonance imaging of  the pancreas 
before and after stimulation with secretin. ACP was diag-
nosed in patients who consumed more than 60 g (females) 
or 80 g (males) of  ethanol per day for more than two years 
before they were diagnosed, during their treatment they 
all gave up drinking alcohol. HCP was diagnosed based 
on the presence of  two fi rst-degree relatives or three or 
more second-degree relatives in two or more generations, 
suffering from recurrent acute pancreatitis or chronic pan-
creatitis for which there was no precipitating factor. For 
comparison, we collected a control group consisting of  
35 healthy subjects. We recruited our healthy controls by 
advertisement in a local paper and did not apply any mon-
etary incentive for the controls to participate.
Analysis of thiols
Samples of  blood were taken by venapuncture into EDTA 
tubes. Whole blood was centrifuged at 1500 × g for 10 
min within 1 h after collection and plasma was stored at 
-30℃ until analysis. Concentrations of  the thiols including 
cysteine, homocysteine, cysteinylglycine and glutathione 
(the sum of  reduced-, oxidised- and protein-bound thiols) 
in plasma were quantifi ed using high performance liquid 
chromatography (HPLC) with fluorescent detection, es-
sentially as described by Fortin et al[21] and modified by 
Raijmakers et al[22]. Thiol levels were calculated using four-
point calibration curves for each thiol, which were run in 
parallel with the samples, and values were expressed in 
μmol/L.
Analysis of FRAP
The antioxidant capacity in blood plasma was measured 
using the ferric reducing ability of  plasma (FRAP) assay, 
according to the method of  Benzie and Strain[23]. The 
reduction of  ferric to ferrous ion at low pH formed a 
coloured ferrous-tripyridyltriazine complex. Absorbance 
changes were linear over a wide concentration range with 
antioxidant mixtures, including plasma. FRAP values were 
obtained using a seven-point calibration curve of  known 
amounts of  Fe2+ and expressed in mmol Fe2+/L.
Analysis of protein carbonyls
The amount of  oxidative protein damage, as a marker for 
oxidative stress, was determined using an enzyme linked 
immunosorbent assay (ELISA) for estimation of  protein 
carbonyls in body fl uids, as essentially described by Buss 
et al[24] and adapted by Zusterzeel et al[25]. Samples were 
incubated with dinitrophenylhydrazine and then adsorbed 
to wells of  an ELISA plate before probing with a com-
mercial antibody raised against protein-conjugated dini-
trophenylhydrazine. The binding of  biotin-conjugated 
primary antibody was then quantifi ed after incubation with 
streptavidin-biotinylated horseradish peroxidase and stain-
ing with o-phenylenediamine. Calibration took place using 
oxidised and fully reduced albumin, and carbonyl levels 
were expressed in μmol/g protein.
Analysis of TBARS
Thiobarbituric acid-reactive substances (TBARS), mainly 
malondialdehyde (MDA) in plasma were evaluated by re-
cording the fl uorescence spectrum between 500 and 600 
nm on a Shimadzu RFF-5000 spectrofl uorometer, of  the 
thiobarbituric acid-malonaldehyde complex, as described 
by Conti et al[26]. Levels of  TBARS were expressed in μmol 
MDA/L.
Analysis of ROS
ROS production in whole blood was evaluated using lu-
minol- enhanced chemiluminescence, as measured in an 
automated LB96V Microlumat Plus Luminometer (EG 
& G Berthold, Belgium). Briefly, the signal-amplifying 
molecule luminol reacts with oxygen species (mainly su-
peroxide anion) generated by neutrophils in whole blood, 
to produce an excited state intermediate that emits light 
as it returns to its ground state. ROS production was de-
termined in the absence of  a cellular stimulator, as well as 
in the presence of  either a receptor-dependent (serum-
treated zymosan, STZ) or a receptor-independent stimulus 
(phorbol 12-myritate 13-acetaat, PMA). Freshly obtained 
heparinized blood was 1:100 diluted in HBSS containing 1 
mmol/L calcium. Two hundred μL of  this diluted blood 
was added to each well of  a 96-well plate. In addition, re-
action mixtures contained 0.45 g/L bovine serum albumin 
(BSA), 0.83 mmol/L luminol and either 1 g/L STZ, 0.4 
mg/L PMA or no stimulating agents. As an internal posi-
tive control for the luminescence process, samples of  1 
g/L ammonium persulphate (APS) in phosphate-buffered 
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solution (PBS) were run simultaneously. Chemilumines-
cence was monitored every 60 s for 1 h. EDTA blood, 
taken together with the heparinized blood samples, was 
tested for leukocyte counts and differentiation, in order to 
adjust the chemiluminescence produced during one hour 
(‘area under the curve’) in relative light units (RLU) per cell 
for neutrophil counts. All measurements were performed 
in quadruplicate and corrected for background values (ab-
sence of  a stimulus). Opsonized zymosan particles were 
prepared by incubation of  STZ with pooled human serum 
for 30 min at 37℃, as previously described[27]. These parti-
cles were then washed twice in PBS and fi nally suspended 
at 12.5 g/L in PBS.
Statistical analysis
Data were analysed using SPSS version 12.0. Differences 
in the baseline characteristics of  patients and controls were 
estimated with Fisher’s exact test and Student’s t-test. The 
Mann-Witney U-test was used to estimate differences in 
biochemical parameters between the patient and control 
population in a non-parametrical manner. Differences were 
considered signifi cant if  P < 0.05. Finally, we examined the 
correlation between the non-enzymatic antioxidant capac-
ity with the amount of  oxidative protein and lipid damage 
in CP patients, using Spearman rank correlation test.
RESULTS
The characteristics of  patients with CP and healthy con-
trols are denoted in Table 1. The mean age of  the CP 
patients was 51 years (range 25 to 74 years) and was not 
signifi cantly different from that of  the healthy controls (45 
years; range 27 to 68 years). There was no signifi cant dif-
ference in the distribution of  gender between CP patients 
and healthy control subjects. Smoking habits between CP 
patients and healthy controls were not different; 66% of  
the patients and 63% of  the control subjects smoked or 
stopped smoking within the last 5 years. 
The oxidative stress was measured in CP patients and 
healthy controls. The plasma concentrations of  cyste-
ine (Cys), homocysteine (Hcys), cysteinylglycine (CGS) 
and glutathione (GSH), the plasma antioxidant capacity 
(FRAP) as well as the plasma levels of  protein carbonyls 
and TBARS and chemoluminescense in whole blood are 
depicted in Table 2.
The plasma concentrations of  antioxidative thiols 
including cysteine, cysteinylglycine and glutathione were 
significantly lower in the CP patients than in the con-
trols (P = 0.021, P = 0.003 and P = 0.048, respectively). 
The plasma levels of  homocysteine were similar in both 
groups. The antioxidant capacity as measured by the FRAP 
assay was also signifi cantly lower in the CP patients than 
in the healthy control subjects (P < 0.001). The levels of  
both carbonyls and TBARS were signifi cantly higher in the 
CP patients than in the healthy controls (P < 0.001). The 
chemiluminescence of  diluted whole blood of  CP patients 
and controls was not different, although there was a strong 
trend towards an increased ROS production after stimula-
tion with PMA (P = 0.058). As expected, spontaneous 
generation of  ROS in the absence of  a stimulus was less 
than 10% of  the amount of  ROS measured in response to 
the stimuli of  PMA and STZ. The leukocyte counts and 
differentiation within the ranges were considered normal 
at our hospital. The values obtained with either assay were 
not different in patients with ACP and HCP.
In addition, the correlation between the non-enzymatic 
antioxidant capacity with the amount of  oxidative protein 
and lipid damage in CP patients was examined and a nega-
tive correlation was found between the non-enzymatic 
antioxidant capacity and the amount of  oxidative protein 
damage (rs = -0.44, P = 0.013), as well as between the non-
enzymatic antioxidant capacity and the amount of  lipid 
damage (rs = -0.39, P = 0.004). Finally, we found a positive 
correlation between oxidative protein and lipid damage (rs 
= 0.67, P = 0.001).
DISCUSSION
Alcohol abuse is regarded as a major risk factor for the de-
velopment of  CP. However, the exact mechanism behind 
the effect of  alcohol remains unknown. Some evidence 
obtained by animal studies, suggests that metabolism of  
ethanol catalysed by cytochrome P4502E1 (CYP2E1) may 
contribute to oxidative stress in the pancreas during chron-
ic alcohol consumption[19]. Trauma, exposure to radiation, 
cigarette smoke, medication or other toxins generating free 
Table 1  Main characteristics of patients with chronic 
pancreatitis and healthy controls
Characteristic CP patients              Controls
n 35                                      35
Gender
      Male/Female 17/18                                18/17
Mean age (yr) (range) 51(25-74)                           45 (27- 68)
Smoking
      Yes/No 23/12                                 22/13
Table 2  Thiol plasma concentrations, FRAP antioxidant 
capacity, protein carbonyl plasma levels, TBARS plasma levels 
and ROS production in whole blood of patients with CP and 
controls mean (range)
Measure for oxidative stress CP patients                    Controls
Cys1 (μmol/L) 225 (124-314)a                249 (212-328)
Hcys2 (μmol/L)   13.6 (5.0-38.2)                12.7 (0.2-27.8)
CGS3 (μmol/L)   34.8 (23.5-124)a              39.3 (25.2-56.7)
GSH4 (μmol/L)     7.5 (2.4-18.5)a                 8.9 (3.5-16.1)
FRAP5 (mmol Fe2+/L)     0.75 (0.31-1.73)a             0.99 (0.69-1.57)
Carbonyls (nmol/mg protein)     0.32 (0.02-1.47)a             0.04 (0.01-0.07)
TBARS6 (μmol/L)     4.98 (0.23-27.79)a           0.35 (0.04-0.68)
ROS7 production (RLU/104 cells)
    PMA8-stimulated   40 (1-83)                          33 (1-87)
    STZ9-stimulated 124 (11-266)                     111 (9-2130)
1Cysteine; 2Homocysteine; 3Cysteinylglycine; 4Glutathione; 5Ferric 
reducing ability of plasma; 6Thiobarbituric acid-reactive substances; 
7Reactive oxygen species; 8Phorbol 12-myritate 13-acetate; 9Serum treated 
zymosan. aP < 0.05 vs control. 
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radicals also may increase the amount of  oxidants. In the 
present study, we assessed the antioxidant capacity and lev-
els of  oxidative damage in CP patients as compared with 
healthy controls by means of  several analytical techniques 
that are known to measure various components that to-
gether constitute oxidative stress. The major observations 
were that plasma concentrations of  some thiols, having 
antioxidant properties, were signifi cantly lower in CP pa-
tients. Likewise the non-enzymatic antioxidant capacity 
as measured by the FRAP assay, was signifi cantly lower in 
CP patients than in healthy control subjects. This inferior 
antioxidant capacity in CP patients parallels significantly 
increased amounts of  oxidative protein and lipid damage, 
whereas the generation of  ROS in whole blood did not 
show a statistically signifi cant difference between CP pa-
tients and healthy control subjects, with a similar age and 
gender distribution and smoking habits. Our results clearly 
indicate that oxidative stress is present in patients with CP 
and that this eventually might contribute to the initiation 
and maintenance of  infl ammation in CP patients, as has 
been previously suggested[17,19,28-31]. Thiols such as cysteine 
and glutathione play an essential role as antioxidants, and 
are involved in protein synthesis, redox sensitive transduc-
tion signalling, cell growth and proliferation, xenobiotic 
metabolism and immune regulation[32]. Glutathione is con-
jugated to many xenobiotics and essential for the optimal 
functioning of  numerous enzymes and hence crucial for 
cell viability. Decreased levels of  glutathione in plasma 
have been reported, but paradoxically also increased glu-
tathione levels may be found as a result of  outshoot after 
enhanced synthesis due to oxidative stress or conjuga-
tion of  toxic compounds, as has been shown in different 
disorders[33-35]. We found significantly lower plasma con-
centrations of  cysteine, cysteinylglycine and glutathione 
in CP patients as compared to healthy controls, whereas 
the control values measured here can be considered nor-
mal for the Dutch population[36]. We found no elevated 
concentrations of  homocysteine in CP patients, how-
ever homocysteine does not always act as an antioxidant, 
moreover elevated plasma concentrations of  homocysteine 
are positively associated with an increased risk of  cerebral, 
coronary or peripheral vascular diseases[36]. In parallel with 
the lower plasma concentrations of  the antioxidative thi-
ols, the FRAP assay also demonstrated a signifi cantly lower 
antioxidant capacity in CP patients. Since the FRAP assay 
does not measure sulfhydryl (SH)-containing antioxidants 
such as the thiols glutathione and cysteine, this indicates 
that other non-thiol related antioxidants are decreased in 
CP patients also. In patients with acute pancreatitis very 
low ascorbate concentrations in plasma have been de-
scribed before [37,38].
Protein carbonyl derivates are generated by direct 
oxidative attack of  proteins or by indirect lipid peroxida-
tion products and therefore represent a good biomarker 
for general oxidative stress[39,40]. The lower FRAP levels in 
CP patients are accompanied with high protein carbonyl 
concentrations, indicating that increased oxidative dam-
age occurs as a result of  the lower protective capacity as 
measured by FRAP. Former studies have demonstrated 
elevated plasma protein carbonyls in experimental animal 
models[41,42] and humans with acute pancreatitis[43]. Unless 
properly scavenged, ROS may lead to lipid peroxidation, 
which represents an important manifestation of  oxidative 
stress. Lipid peroxidation is initiated when free radicals 
interact with polyunsaturated fatty acids. For instance, in 
cell membranes this may result in a chain reaction forming 
lipid hydroperoxides. Analysis of  TBARS in plasma is a 
widely used method for the estimation of  lipid peroxida-
tion. In accordance with the elevated levels of  protein 
carbonyls and lower antioxidant capacity, we found signifi -
cantly increased plasma concentrations of  TBARS in CP 
patients. The production of  ROS, as measured in whole 
blood by chemiluminescence assay, was not significantly 
higher in CP patients than in healthy controls, although 
there was a strong trend to generate higher amounts of  
ROS after stimulation with PMA. We used luminol-en-
hanced chemiluminescence assay in 100-fold diluted whole 
blood to study ROS generation of  peripheral blood cells 
in a non-disturbed system. As expected, ROS generation 
in the absence of  a stimulus in CP patients was low, and 
not significantly different from the values in the healthy 
control group. Chemiluminescence measurements did not 
demonstrate a significantly increased ROS generation in 
CP patients, while the other analytical techniques applied 
here showed increased oxidative stress and damage in CP 
patients as compared to healthy control subjects, demon-
strating that the oxidative damage in CP patients is caused 
by other reactive (oxygen) species rather than by leuco-
cytes. Since most of  the CP patients included in this study 
were alcoholics, the cause of  oxidative damage might be 
mainly of  exogenous origin. However, a contribution of  
oxidative stress of  endogenous origin might also be pos-
sible, since we detected a strong tendency to produce ROS 
in CP patients after stimulation with PMA. This PMA-
induced respiratory burst is receptor-independent and not 
absolutely dependent on priming[44], whereas priming does 
moderately infl uence the STZ-induced respiratory burst[45]. 
We measured the ROS production in whole blood and it is 
known that during isolation of  neutrophils, these cells of-
ten become primed[46]. The clinical importance of  oxidative 
stress in human pancreatic disease was fi rst suggested by 
Braganza et al[47], and subsequently supported by data from 
other groups, showing increased levels of  lipid hydroper-
oxides in pancreatic juice[14] and increased spontaneous 
production of  ROS by neutrophils[27,48]. The assessment of  
oxidative stress in CP patients corroborates the hypothesis 
that oxidative stress leads to damage of  pancreatic acinar 
cells, initiating auto-digestion of  the entire pancreas as has 
been shown in the present study. 
In summary, signifi cantly higher levels of  products of  
oxidative damage (protein carbonyls and TBARS), cor-
relating with decreased levels of  cysteine, cysteinylglycine, 
glutathione and non-enzymatic antioxidant capacity (FRAP) 
can be found in CP patients. Oxidative stress, defi ned as 
the imbalance between prooxidant and antioxidant capac-
ity, is higher in CP patients, which may justify further stud-
ies on intervention with antioxidant therapies for this seri-
ous disease. 
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